You are here

Novo Nordisk

Novo Nordisk continues pushing beyond diabetes, netting PhII win for former Corvidia kidney program

Endpoints

Tue, 05/18/21 - 11:00 am

chronic kidney disease

clinical trials

Recall report: Novo Nordisk recalls samples of multiple insulin products after storage screw-up

Endpoints

Thu, 05/13/21 - 10:47 am

product recalls

Novo Nordisk recalls sales rep samples sunk by Texas power outages

Fierce Pharma

Mon, 05/10/21 - 09:46 pm

Ahead of potential Ozempic approval in obesity, Novo hits 'full go mode' for launch, exec says

Fierce Pharma

Wed, 05/5/21 - 11:09 am

AbbVie's Humira regains top pharma TV spender spot, while sibling brands Rinvoq and Skyrizi tag along

Fierce Pharma

Wed, 05/5/21 - 10:50 am

DTC advertising

Novo Nordisk ups forecasts after Q1 profit boost

Pharmaforum

Wed, 05/5/21 - 10:46 am

Novo Nordisk to launch PhIII obesity trial for oral semaglutide

Endpoints

Wed, 04/21/21 - 11:17 pm

oral semaglutide

clinical trials

Pharma's pandemic reputation gains score a 'most-improved' medal in annual ranking

Fierce Pharma

Mon, 04/12/21 - 10:58 pm

pharma industry

Bristol Myers Squibb

Big pharma freshens up

EP Vantage

Fri, 04/9/21 - 10:35 am

Bristol Myers Squibb

FDA Asks Novo Nordisk For More Information On Semaglutide Label Expansion Application

Benzinga

Tue, 03/23/21 - 10:25 am

Gilead, Novo Nordisk push NASH cocktail deeper into the clinic

Fierce Biotech

Thu, 03/18/21 - 10:54 am

Gilead Sciences

GSK, Novo and Roche meds hit pandemic potholes while Dupixent, Humira stood strong: analysts

Fierce Pharma

Sat, 03/13/21 - 10:19 pm

Lilly has its Ozempic-beating data from a head-to-head diabetes trial. Should Novo Nordisk be worried?

Fierce Pharma

Sun, 03/7/21 - 01:27 pm

clinical trials

Lilly's tirzepatide beats Novo's semaglutide in diabetes phase 3, but another study muddies picture

Fierce Biotech

Thu, 03/4/21 - 10:05 am

type 2 diabetes

clinical trials

Watch out, Novo Nordisk. Lilly's new dual action diabetes med could pressure Ozempic: analyst

Fierce Pharma

Tue, 02/23/21 - 10:56 pm

Novo Nordisk's blockbuster diabetes drug blows the doors off in obesity, proving highly effective in driving weight loss

Endpoints

Thu, 02/11/21 - 10:43 am

Novo Nordisk plots $1.3B in spending as it expands API production—and advances new oral meds

Fierce Pharma

Thu, 02/4/21 - 10:43 am

drug manufacturing

Novo Nordisk files for regulatory approval in the US of once-weekly semaglutide 2.0 mg for the treatment of type 2 diabetes

Yahoo/Global Newswire

Wed, 01/20/21 - 10:39 am

type 2 diabetes

Pharma TV ad spenders blow up December with spendiest month of 2020

Fierce Pharma

Wed, 01/6/21 - 10:50 am

Novo Nordisk’s gene silencing alliance with Dicerna bears first fruit

Pharmaforum

Wed, 01/6/21 - 10:42 am

Pages